Jennifer Vega to Humans
This is a "connection" page, showing publications Jennifer Vega has written about Humans.
Connection Strength
0.140
-
Vega JN, Albert KM, Mayer IA, Taylor WD, Newhouse PA. Subjective cognition and mood in persistent chemotherapy-related cognitive impairment. J Cancer Surviv. 2022 06; 16(3):614-623.
Score: 0.027
-
Vega JN, Albert KM, Mayer IA, Taylor WD, Newhouse PA. Nicotinic treatment of post-chemotherapy subjective cognitive impairment: a pilot study. J Cancer Surviv. 2019 Oct; 13(5):673-686.
Score: 0.024
-
Vega JN, Dumas J, Newhouse PA. Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause. Psychooncology. 2018 09; 27(9):2198-2205.
Score: 0.022
-
Vega JN, Dumas J, Newhouse PA. Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults. Am J Geriatr Psychiatry. 2017 Dec; 25(12):1415-1426.
Score: 0.020
-
Vega JN, Hohman TJ, Pryweller JR, Dykens EM, Thornton-Wells TA. Resting-State Functional Connectivity in Individuals with Down Syndrome and Williams Syndrome Compared with Typically Developing Controls. Brain Connect. 2015 Oct; 5(8):461-75.
Score: 0.018
-
Vega JN, Newhouse PA. Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments. Curr Psychiatry Rep. 2014 Oct; 16(10):490.
Score: 0.017
-
Andrews P, Vega JN, Szymkowicz SM, Newhouse P, Tyndale R, Elson D, Kang H, Siddiqi S, Tyner EB, Mather K, Gunning FM, Taylor WD. Effects of open-label transdermal nicotine antidepressant augmentation on affective symptoms and executive function in late-life depression. J Affect Disord. 2024 Oct 01; 362:416-424.
Score: 0.008
-
Meda SA, Koran ME, Pryweller JR, Vega JN, Thornton-Wells TA. Genetic interactions associated with 12-month atrophy in hippocampus and entorhinal cortex in Alzheimer's Disease Neuroimaging Initiative. Neurobiol Aging. 2013 May; 34(5):1518.e9-18.
Score: 0.004